A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 185,113 shares of VRTX stock, worth $75.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
185,113
Previous 190,128 2.64%
Holding current value
$75.6 Million
Previous $89.1 Million 3.39%
% of portfolio
0.2%
Previous 0.21%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $2.31 Million - $2.54 Million
-5,015 Reduced 2.64%
185,113 $86.1 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $9.22 Million - $11.4 Million
-23,462 Reduced 10.98%
190,128 $89.1 Million
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $6.53 Million - $7.15 Million
-16,028 Reduced 6.98%
213,590 $89.3 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $6.89 Million - $8.25 Million
20,090 Added 9.59%
229,618 $93.4 Million
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $2.39 Million - $2.57 Million
-7,080 Reduced 3.27%
209,528 $72.9 Million
Q2 2023

Aug 08, 2023

SELL
$314.42 - $351.91 $2.1 Million - $2.35 Million
-6,671 Reduced 2.99%
216,608 $76.2 Million
Q1 2023

May 10, 2023

SELL
$283.23 - $323.1 $3.31 Million - $3.78 Million
-11,693 Reduced 4.98%
223,279 $70.3 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $2.52 Million - $2.83 Million
-8,809 Reduced 3.61%
234,972 $67.9 Million
Q3 2022

Nov 10, 2022

SELL
$273.83 - $305.53 $9.42 Million - $10.5 Million
-34,409 Reduced 12.37%
243,781 $70.6 Million
Q2 2022

Aug 09, 2022

BUY
$234.96 - $292.55 $7.62 Million - $9.49 Million
32,446 Added 13.2%
278,190 $78.4 Million
Q1 2022

May 12, 2022

SELL
$221.42 - $260.97 $2 Million - $2.36 Million
-9,025 Reduced 3.54%
245,744 $64.1 Million
Q4 2021

Feb 09, 2022

SELL
$177.01 - $223.45 $3.18 Million - $4.02 Million
-17,977 Reduced 6.59%
254,769 $55.9 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $298,023 - $333,512
1,643 Added 0.61%
272,746 $49.5 Million
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $1.34 Million - $1.58 Million
7,140 Added 2.7%
271,103 $54.6 Million
Q1 2021

May 12, 2021

SELL
$207.02 - $241.31 $13.1 Million - $15.3 Million
-63,204 Reduced 19.32%
263,963 $56.9 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $16.3 Million - $21.7 Million
78,637 Added 31.64%
327,167 $77.3 Million
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $993,967 - $1.18 Million
3,888 Added 1.59%
248,530 $67.6 Million
Q2 2020

Sep 11, 2020

SELL
$225.48 - $295.8 $5.49 Million - $7.2 Million
-24,353 Reduced 9.05%
244,642 $71 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $13.3 Million - $17.4 Million
58,900 Added 28.03%
268,995 $71 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $2.8 Million - $3.48 Million
14,035 Added 7.16%
210,095 $50 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $51,846 - $69,636
-311 Reduced 0.16%
196,060 $42.9 Million
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $497,858 - $560,334
-2,995 Reduced 1.5%
196,371 $32.8 Million
Q2 2019

Aug 07, 2019

SELL
$164.61 - $190.37 $7.04 Million - $8.14 Million
-42,783 Reduced 17.67%
199,366 $35.6 Million
Q1 2019

May 13, 2019

SELL
$163.73 - $194.7 $15.2 Million - $18.1 Million
-93,050 Reduced 27.76%
242,149 $44.2 Million
Q4 2018

Feb 12, 2019

SELL
$151.91 - $192.21 $854,341 - $1.08 Million
-5,624 Reduced 1.65%
335,199 $55.5 Million
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $55 Million - $63.2 Million
-327,920 Reduced 49.04%
340,823 $65.7 Million
Q2 2018

Aug 10, 2018

BUY
$145.72 - $169.96 $812,680 - $947,866
5,577 Added 0.84%
668,743 $114 Million
Q1 2018

May 11, 2018

BUY
$151.6 - $177.13 $356,411 - $416,432
2,351 Added 0.36%
663,166 $108 Million
Q4 2017

Feb 09, 2018

BUY
$137.28 - $155.55 $58,344 - $66,108
425 Added 0.06%
660,815 $99 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $97.8 Million - $107 Million
660,390
660,390 $100 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.